| Identification | Back Directory | [Name]
Eprotirome | [CAS]
355129-15-6 | [Synonyms]
Kb-2115
eprotirome
Unii-958aq7B6R1
KB2115 Exclusive
VPCSYAVXDAUHLT-UHFFFAOYSA-N
N-[3,5-Dibromo-4-(4-hydroxy-3-isopropylphenoxy)phenyl]malonamic acid
3-((3,5-Dibromo-4-(4-hydroxy-3-(1-methylethyl)phenoxy)phenyl)amino)-3-oxopropanoic acid
Propanoic acid,3-[[3,5-dibroMo-4-[4-hydroxy-3-(1-Methylethyl)phenoxy]phenyl]aMino]-3-oxo- | [Molecular Formula]
C18H17Br2NO5 | [MDL Number]
MFCD11045847 | [MOL File]
355129-15-6.mol | [Molecular Weight]
487.14 |
| Chemical Properties | Back Directory | [Boiling point ]
596.3±50.0 °C(Predicted) | [density ]
1.708 | [storage temp. ]
Sealed in dry,Room Temperature | [solubility ]
DMSO:84.0(Max Conc. mg/mL);172.43(Max Conc. mM)
DMF:30.0(Max Conc. mg/mL);61.58(Max Conc. mM)
Ethanol:63.5(Max Conc. mg/mL);130.35(Max Conc. mM)
Ethanol:PBS (pH 7.2) (1:1):0.5(Max Conc. mg/mL);1.03(Max Conc. mM) | [form ]
A crystalline solid | [pka]
3.16±0.32(Predicted) | [color ]
White to light yellow |
| Hazard Information | Back Directory | [Uses]
Eprotirome, is a liver-selective thyroid hormone receptor agonist. | [in vivo]
Eprotirome is a liver-selective thyroid hormone receptor agonist. Histological analysis of livers from mice treated with Eprotirome reveals that Eprotirome elicits a near complete elimination of lipid filled vacuoles that are characteristic of the livers from untreated control mice. Eprotirome treated mice also exhibit increased fasting glucose, but Eprotirome does not increase fasting insulin levels. Glucose levels of mice treated with Eprotirome continues to increase over time, leading to pronounced hyperglycemia by the end of the study. Temperature of mice treated with Eprotirome is decreased relative to untreated control mice[1]. |
|
| Company Name: |
DC Chemicals
|
| Tel: |
021-58447131 13564518121 |
| Website: |
http://www.yuhua99.com/ShowSupplierProductsList927327/0.htm |
|